Catalyst Biosciences

Research, Protease engineering & proteases in hemostasis, Biotechnology, Life sciences, Research
Founded in 1997
South San Francisco, California
http://www.catalystbiosciences.com
None

About Catalyst Biosciences

Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems.Our protease engineering platform generated two late-stage clinical programs in hemophilia; a research program on engineering of subcutaneous (SQ) complement inhibitors; a discovery stage Factor IX gene therapy construct - CB 2679d-GT - for Hemophilia B, and a partnered preclinical development program with Biogen for dry age-related macular degeneration (AMD). The product candidates generated by our protease engineering platform have improved functionality and potency that allow for: SQ administration of recombinant coagulation factors and complement inhibitors; low-dose, high activity gene therapy constructs; and less frequently dosed intravitreal therapeutics.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 32.6M None
  • Last Funding: 5M None (None)
  • Funding Status: None

Technology Stack

Catalyst Biosciences actively uses None products in their tech stack.

Market Presence

Industries: Research, Protease engineering & proteases in hemostasis, Biotechnology, Life sciences, Research

Headquarters: South San Francisco, California